HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION — Lobbying Disclosure | Poliscope

HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION

View full entity profile (contributions, contracts, SEC) →

This entity appears on both sides of lobbying disclosures. The firm tab shows registrant-reported income; the client tab shows client-reported lobbying spend. Contract awards are separate and are not included here.

Lobbying Spend

$2.8M

Filings

174

Firms Hired

Active Period

2008–2026

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2026	$194,505	3	1
2025	$120,000	10	2
2024	$120,000	8	2
2023	$120,000	11	3
2022	$66,000	8	2
2021	$480,000	12	3
2020	$120,000	10	3
2019	$120,000	8	2
2018	$120,000	8	2
2017	$120,000	8	2
2016	$160,000	10	3
2015	$200,000	13	3
2014	$125,000	13	3
2013	$156,592	9	2
2012	$121,569	8	2
2011	$120,000	8	2
2010	$120,000	8	2
2009	$130,000	9	2
2008	$110,000	10	2

Hired Firms

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION	$2,823,665	76
WEST FRONT STRATEGIES LLC	—	41
BRYAN CAVE LEIGHTON PAISNER	—	24
AVENUE SOLUTIONS	—	6
BRYAN CAVE STRATEGIES LLC	—	6
S-3 GROUP	—	6
THE D MAJOR GROUP	—	12
KD GOVERNMENT RELATIONS, LLC	—	3

Government Bodies Lobbied

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
SENATE	163
HOUSE OF REPRESENTATIVES	162
Health & Human Services, Dept of (HHS)	99
Centers For Medicare and Medicaid Services (CMS)	60
Food & Drug Administration (FDA)	56
White House Office	25
Federal Emergency Management Agency (FEMA)	23
Internal Revenue Service (IRS)	23
General Services Administration (GSA)	21
Commerce, Dept of (DOC)	20
U.S. Trade Representative (USTR)	20
Federal Maritime Commission	19
Transportation, Dept of (DOT)	19
Environmental Protection Agency (EPA)	12
Centers For Disease Control & Prevention (CDC)	6
U.S. Customs & Border Protection	3
Treasury, Dept of	1

Top Issues

Most frequently reported lobbying issues

Issue Code	Description	Reports
Health Issues	Health Issues	167
Transportation	Transportation	21
Tariff (miscellaneous tariff bills)	Tariff (miscellaneous tariff bills)	15
Budget/Appropriations	Budget/Appropriations	12
Medicare/Medicaid	Medicare/Medicaid	11
Environment/Superfund	Environment/Superfund	7
Disaster Planning/Emergencies	Disaster Planning/Emergencies	5
Pharmacy	Pharmacy	4
Small Business	Small Business	3
Homeland Security	Homeland Security	3
Defense	Defense	3
Taxation/Internal Revenue Code	Taxation/Internal Revenue Code	2
Medical/Disease Research/Clinical Labs	Medical/Disease Research/Clinical Labs	1

Bills Explicitly Cited (25)

Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded

H.R. 2213119th Congress

Medical Supply Chain Resiliency Act

2026 · third_quarter · Firm: HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION

Open original LDA filing ↗

Cited source text and reported amounts

Legislative and executive branch action with respect to tariffs and tariff exclusions on medical products: including Section 122 tariffs and tariff investigations pursuant to Sec 301 and Sec 232 on medical products. Medical Supply Chain Resiliency Act (S. 998/HR 2213)

Client expense: $60,505 · Firm income: —

Matched citations: HR 2213

H.R. 2213119th Congress

Medical Supply Chain Resiliency Act

2026 · third_quarter · Firm: HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION

Open original LDA filing ↗

Cited source text and reported amounts

Medical Supply Chain Resiliency Act (S. 998/HR 2213). Reauthorization of the Pandemic and All-Hazards Preparedness Act (PAHPA).

Client expense: $60,505 · Firm income: —

Matched citations: HR 2213

S. 998119th Congress

Medical Supply Chain Resiliency Act

2026 · third_quarter · Firm: HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION

Open original LDA filing ↗

Cited source text and reported amounts

Medical Supply Chain Resiliency Act (S. 998/HR 2213). Reauthorization of the Pandemic and All-Hazards Preparedness Act (PAHPA).

Client expense: $60,505 · Firm income: —

Matched citations: S. 998

S. 998119th Congress

Medical Supply Chain Resiliency Act

2026 · third_quarter · Firm: HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION

Open original LDA filing ↗

Cited source text and reported amounts

Legislative and executive branch action with respect to tariffs and tariff exclusions on medical products: including Section 122 tariffs and tariff investigations pursuant to Sec 301 and Sec 232 on medical products. Medical Supply Chain Resiliency Act (S. 998/HR 2213)

Client expense: $60,505 · Firm income: —

Matched citations: S. 998

Show 21 more cited filings

H.R. 2213119th Congress

Medical Supply Chain Resiliency Act

2026 · second_quarter · Firm: HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION

Open original LDA filing ↗

Cited source text and reported amounts

Legislative and executive branch action with respect to tariffs and tariff exclusions on medical products: including Section 122 tariffs and tariff investigations pursuant to Sec 301 and Sec 232 on medical products. Medical Supply Chain Resiliency Act (S. 998/HR 2213)

Client expense: $67,000 · Firm income: —

Matched citations: HR 2213

H.R. 2213119th Congress

Medical Supply Chain Resiliency Act

2026 · second_quarter · Firm: HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION

Open original LDA filing ↗

Cited source text and reported amounts

Medical Supply Chain Resiliency Act (S. 998/HR 2213). Reauthorization of the Pandemic and All-Hazards Preparedness Act (PAHPA).

Client expense: $67,000 · Firm income: —

Matched citations: HR 2213

S. 998119th Congress

Medical Supply Chain Resiliency Act

2026 · second_quarter · Firm: HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION

Open original LDA filing ↗

Cited source text and reported amounts

Legislative and executive branch action with respect to tariffs and tariff exclusions on medical products: including Section 122 tariffs and tariff investigations pursuant to Sec 301 and Sec 232 on medical products. Medical Supply Chain Resiliency Act (S. 998/HR 2213)

Client expense: $67,000 · Firm income: —

Matched citations: S. 998

S. 998119th Congress

Medical Supply Chain Resiliency Act

2026 · second_quarter · Firm: HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION

Open original LDA filing ↗

Cited source text and reported amounts

Medical Supply Chain Resiliency Act (S. 998/HR 2213). Reauthorization of the Pandemic and All-Hazards Preparedness Act (PAHPA).

Client expense: $67,000 · Firm income: —

Matched citations: S. 998

H.R. 2213119th Congress

Medical Supply Chain Resiliency Act

2026 · first_quarter · Firm: HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION

Open original LDA filing ↗

Cited source text and reported amounts

Legislative and executive branch action with respect to tariffs and tariff exclusions on medical products: including Section 122 tariffs and tariff investigations pursuant to Sec 301 and Sec 232 on medical products. Medical Supply Chain Resiliency Act (S. 998/HR 2213)

Client expense: $67,000 · Firm income: —

Matched citations: HR 2213

H.R. 2213119th Congress

Medical Supply Chain Resiliency Act

2026 · first_quarter · Firm: HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION

Open original LDA filing ↗

Cited source text and reported amounts

Medical Supply Chain Resiliency Act (S. 998/HR 2213). Reauthorization of the Pandemic and All-Hazards Preparedness Act (PAHPA).

Client expense: $67,000 · Firm income: —

Matched citations: HR 2213

S. 257119th Congress

Promoting Resilient Supply Chains Act of 2025

2026 · first_quarter · Firm: HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION

Open original LDA filing ↗

Cited source text and reported amounts

S.257, the Promoting Resilient Supply Chains Act of 2025.

Client expense: $67,000 · Firm income: —

Matched citations: S.257

S. 998119th Congress

Medical Supply Chain Resiliency Act

2026 · first_quarter · Firm: HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION

Open original LDA filing ↗

Cited source text and reported amounts

Legislative and executive branch action with respect to tariffs and tariff exclusions on medical products: including Section 122 tariffs and tariff investigations pursuant to Sec 301 and Sec 232 on medical products. Medical Supply Chain Resiliency Act (S. 998/HR 2213)

Client expense: $67,000 · Firm income: —

Matched citations: S. 998

S. 998119th Congress

Medical Supply Chain Resiliency Act

2026 · first_quarter · Firm: HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION

Open original LDA filing ↗

Cited source text and reported amounts

Medical Supply Chain Resiliency Act (S. 998/HR 2213). Reauthorization of the Pandemic and All-Hazards Preparedness Act (PAHPA).

Client expense: $67,000 · Firm income: —

Matched citations: S. 998

H.R. 2213119th Congress

Medical Supply Chain Resiliency Act

2025 · fourth_quarter · Firm: HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION

Open original LDA filing ↗

Cited source text and reported amounts

Legislative and executive branch action with respect to tariffs and tariff exclusions on medical products: including IEEPA reciprocal tariffs, IEEPA border/fentanyl tariffs on China, Mexico and Canada, tariff investigations pursuant to Sec 301 and Sec 232 on medical products. Medical Supply Chain Resiliency Act (S. 998/HR 2213)

Client expense: $30,000 · Firm income: —

Matched citations: HR 2213

H.R. 2213119th Congress

Medical Supply Chain Resiliency Act

2025 · fourth_quarter · Firm: HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION

Open original LDA filing ↗

Cited source text and reported amounts

Medical Supply Chain Resiliency Act (S. 998/HR 2213). Reauthorization of the Pandemic and All-Hazards Preparedness Act (PAHPA) either as standalone legislation or inclusion in a larger package such as S.891, the Bipartisan Health Care Act.

Client expense: $30,000 · Firm income: —

Matched citations: HR 2213

S. 257119th Congress

Promoting Resilient Supply Chains Act of 2025

2025 · fourth_quarter · Firm: HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION

Open original LDA filing ↗

Cited source text and reported amounts

S.257, the Promoting Resilient Supply Chains Act of 2025.

Client expense: $30,000 · Firm income: —

Matched citations: S.257

S. 891119th Congress

Bipartisan Health Care Act

2025 · fourth_quarter · Firm: HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION

Open original LDA filing ↗

Cited source text and reported amounts

Medical Supply Chain Resiliency Act (S. 998/HR 2213). Reauthorization of the Pandemic and All-Hazards Preparedness Act (PAHPA) either as standalone legislation or inclusion in a larger package such as S.891, the Bipartisan Health Care Act.

Client expense: $30,000 · Firm income: —

Matched citations: S.891

S. 998119th Congress

Medical Supply Chain Resiliency Act

2025 · fourth_quarter · Firm: HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION

Open original LDA filing ↗

Cited source text and reported amounts

Legislative and executive branch action with respect to tariffs and tariff exclusions on medical products: including IEEPA reciprocal tariffs, IEEPA border/fentanyl tariffs on China, Mexico and Canada, tariff investigations pursuant to Sec 301 and Sec 232 on medical products. Medical Supply Chain Resiliency Act (S. 998/HR 2213)

Client expense: $30,000 · Firm income: —

Matched citations: S. 998

S. 998119th Congress

Medical Supply Chain Resiliency Act

2025 · fourth_quarter · Firm: HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION

Open original LDA filing ↗

Cited source text and reported amounts

Medical Supply Chain Resiliency Act (S. 998/HR 2213). Reauthorization of the Pandemic and All-Hazards Preparedness Act (PAHPA) either as standalone legislation or inclusion in a larger package such as S.891, the Bipartisan Health Care Act.

Client expense: $30,000 · Firm income: —

Matched citations: S. 998

H.R. 6140118th Congress

FAST PASS Act

2025 · third_quarter · Firm: HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION

Open original LDA filing ↗

Cited source text and reported amounts

S.257, the Promoting Resilient Supply Chains Act of 2025. Implementation of HR 6140, enacted as Section 3522 of Public Law 118-159:Facilitating Access to Swiftly Transport Goods during a Publicly Announced State of Emergency Situation (FAST PASS) Act.

Client expense: $30,000 · Firm income: —

Matched citations: HR 6140

H.R. 2213119th Congress

Medical Supply Chain Resiliency Act

2025 · third_quarter · Firm: HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION

Open original LDA filing ↗

Cited source text and reported amounts

Legislative and executive branch action with respect to tariffs and tariff exclusions on medical products: including IEEPA reciprocal tariffs, IEEPA border/fentanyl tariffs on China, Mexico and Canada, tariff investigations pursuant to Sec 301 and Sec 232 on medical products. Medical Supply Chain Resiliency Act (S. 998/HR 2213)

Client expense: $30,000 · Firm income: —

Matched citations: HR 2213

H.R. 2213119th Congress

Medical Supply Chain Resiliency Act

2025 · third_quarter · Firm: HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION

Open original LDA filing ↗

Cited source text and reported amounts

Medical Supply Chain Resiliency Act (S. 998/HR 2213). Reauthorization of the Pandemic and All-Hazards Preparedness Act (PAHPA) either as standalone legislation or inclusion in a larger package such as S.891, the Bipartisan Health Care Act.

Client expense: $30,000 · Firm income: —

Matched citations: HR 2213

S. 257118th Congress

BOLIVAR Act

2025 · third_quarter · Firm: HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION

Open original LDA filing ↗

Cited source text and reported amounts

S.257, the Promoting Resilient Supply Chains Act of 2025. Implementation of HR 6140, enacted as Section 3522 of Public Law 118-159:Facilitating Access to Swiftly Transport Goods during a Publicly Announced State of Emergency Situation (FAST PASS) Act.

Client expense: $30,000 · Firm income: —

Matched citations: S.257

S. 891119th Congress

Bipartisan Health Care Act

2025 · third_quarter · Firm: HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION

Open original LDA filing ↗

Cited source text and reported amounts

Medical Supply Chain Resiliency Act (S. 998/HR 2213). Reauthorization of the Pandemic and All-Hazards Preparedness Act (PAHPA) either as standalone legislation or inclusion in a larger package such as S.891, the Bipartisan Health Care Act.

Client expense: $30,000 · Firm income: —

Matched citations: S.891

S. 998119th Congress

Medical Supply Chain Resiliency Act

2025 · third_quarter · Firm: HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION

Open original LDA filing ↗

Cited source text and reported amounts

Medical Supply Chain Resiliency Act (S. 998/HR 2213). Reauthorization of the Pandemic and All-Hazards Preparedness Act (PAHPA) either as standalone legislation or inclusion in a larger package such as S.891, the Bipartisan Health Care Act.

Client expense: $30,000 · Firm income: —

Matched citations: S. 998

Source: Senate LDA